Word: elys
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Eli Lilly was the last U.S. manufacturer of animal insulin, which is extracted from the pancreatic tissue of cows and pigs and has been used by diabetics for more than a half-century. Lilly stopped selling the drug in March, and its last batch expired April 1. From now on, it will sell only synthetic human insulin produced by recombinant-DNA technology...
Harvard and three other parties are facing off against pharmaceutical giant Eli Lilly in federal court over a patent dispute that could have implications on the validity of certain kinds of biotechnology patents. The University and co-plaintiffs MIT, the Whitehead Institute for Biomedical Research, and Ariad Pharmaceuticals are seeking royalties from two of Eli Lilly’s drugs, Evista and Xigris. The institutions claim the drugs infringe on a patent they were jointly awarded in 2002. The trial began April 10 in U.S. District Court for the District of Massachusetts. Closing arguments are scheduled to take place tomorrow...
...Eli first baseman Marc Sawyer, Brown’s Cape Cod Summer League teammate, saw his 18-game hit streak end on Wednesday at Sacred Heart but enters the weekend hitting an impressive .378 and slugging at a .521 clip...
Shuffler: Eli M. Levenson-Falk ’08 1. “In The Clutches Of The Diabolical Sgt. Stiletto” by 2 Skinnee J’s “The lyrics mean absolutely nothing, and they show an incredible talent for integrating celebrity names into sentences.” 2. “Outside” by Staind “This song was extremely overplayed. Pretty good, but kind of depressing. This is from the angsty teenage years.” 3. “Pardon Me” by Incubus “Probably...
...Eli Lilly's success is personal. In 1990 Rice, 41, decided to join the company that made his diabetic mother's insulin. Says the Alabama native: "I know [now] Lilly is why I've had 24 years longer with my mother." His wife also works for the company. Lilly, whose prospects once seemed dim with the loss in 2001 of its patent for the popular antidepressant Prozac, expects a rise in earnings of up to 12% this year, led by new drugs such as Byetta--for diabetes. At the same time, Lilly has cut its workforce nearly 7% since...